Michael Murray
Psychiatry · Asheville, NCNPI 1023002870
Payments from drug & device makers
Across 197 payments — averaging $19.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$778
- Teva Pharmaceuticals USA, Inc.$601
- AbbVie$399
- Otsuka America Pharmaceutical, Inc.$383
- Neurocrine Biosciences, Inc.$371
- Johnson & Johnson$362
- plus $989 from 7 others
What the payments were for
- Food & beverage$3,883100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 43 | $778 |
| Teva Pharmaceuticals USA, Inc. | 30 | $601 |
| AbbVie(2 entities) | 19 | $399 |
| Otsuka America Pharmaceutical, Inc. | 19 | $383 |
| Neurocrine Biosciences, Inc. | 18 | $371 |
| Johnson & Johnson | 20 | $362 |
| Indivior Inc. | 12 | $263 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $242 |
| E.r. Squibb & Sons, L.L.C. | 11 | $223 |
| Vanda Pharmaceuticals Inc. | 4 | $90 |
| Lundbeck LLC | 5 | $89 |
| Sunovion Pharmaceuticals Inc. | 4 | $56 |
| Axsome Therapeutics, Inc. | 1 | $26 |
How this compares
$3,883 in reported general payments places this provider in the 85th percentile of 1,108 psychiatry providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AristadaAripiprazole Lauroxil | 52 | $162,166 |
| Invega SustennaPaliperidone Palmitate | 41 | $132,189 |
| Abilify MaintenaAripiprazole | 11 | $34,108 |
| VivitrolNaltrexone Microspheres | 14 | $23,744 |
| VraylarCariprazine Hcl | 11 | $16,365 |
| Clozapine OdtClozapine | 24 | $9,409 |
| Clozapine | 49 | $4,131 |
| Paliperidone ErPaliperidone | 14 | $2,755 |
| Aripiprazole | 37 | $2,426 |
| Atomoxetine Hcl | 13 | $2,308 |
| VascepaIcosapent Ethyl | 11 | $2,143 |
| Trazodone Hcl | 77 | $1,433 |
| Gabapentin | 43 | $974 |
| Divalproex Sodium ErDivalproex Sodium | 21 | $744 |
| Prazosin Hcl | 28 | $718 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Alkermes, Inc.Aristada, Vivitrol | $778 | $185,90966 claims |
| Johnson & JohnsonInvega Sustenna | $362 | $132,18941 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $383 | $34,10811 claims |
| AbbVieVraylar | $399 | $16,36511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,108 psychiatry providers in North Carolina.
Other psychiatry in Asheville
- Craig ChepkeHuntersville$4.1M
- James BarkerHickory$4.1M
- Mark ReynoldsDurham$3.2M
- Oleg TcheremissineCharlotte$2M
- Richard WeislerRaleigh$1.2M
- Dan BlazerDurham$1M
- Samantha Meltzer-BrodyChapel Hill$909K
- Andrew KrystalDurham$754K
- Brian FarahWinston Salem$605K
- Krishna TalluriMorrisville$591K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.